272 related articles for article (PubMed ID: 19714754)
1. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease.
Weigert J; Obermeier F; Neumeier M; Wanninger J; Filarsky M; Bauer S; Aslanidis C; Rogler G; Ott C; Schäffler A; Schölmerich J; Buechler C
Inflamm Bowel Dis; 2010 Apr; 16(4):630-7. PubMed ID: 19714754
[TBL] [Abstract][Full Text] [Related]
2. Serum adipokines in inflammatory bowel disease.
Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of C1q/TNF-related protein-3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance.
Mohamadinarab M; Ahmadi R; Gholamrezayi A; Rahvar F; Naghdalipour M; Setayesh L; Moradi N; Fadaei R; Chamani E; Tavakoli T; Esteghamati A
IUBMB Life; 2020 Aug; 72(8):1698-1704. PubMed ID: 32311832
[TBL] [Abstract][Full Text] [Related]
5. Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease.
Terzoudis S; Malliaraki N; Damilakis J; Dimitriadou DA; Zavos C; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):814-9. PubMed ID: 26934527
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
[TBL] [Abstract][Full Text] [Related]
7. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.
Valentini L; Wirth EK; Schweizer U; Hengstermann S; Schaper L; Koernicke T; Dietz E; Norman K; Buning C; Winklhofer-Roob BM; Lochs H; Ockenga J
Nutrition; 2009 Feb; 25(2):172-81. PubMed ID: 18849144
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity.
Yilmaz Y; Yonal O; Eren F; Atug O; Hamzaoglu HO
J Crohns Colitis; 2011 Oct; 5(5):402-6. PubMed ID: 21939913
[TBL] [Abstract][Full Text] [Related]
9. Decreased levels of serum omentin-1 in patients with inflammatory bowel disease.
Yin J; Hou P; Wu Z; Nie Y
Med Sci Monit; 2015 Jan; 21():118-22. PubMed ID: 25576244
[TBL] [Abstract][Full Text] [Related]
10. Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.
Kader HA; Tchernev VT; Satyaraj E; Lejnine S; Kotler G; Kingsmore SF; Patel DD
Am J Gastroenterol; 2005 Feb; 100(2):414-23. PubMed ID: 15667502
[TBL] [Abstract][Full Text] [Related]
11. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
12. Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn's disease and ulcerative colitis.
Chouliaras G; Panayotou I; Margoni D; Mantzou E; Pervanidou P; Manios Y; Chrousos GP; Roma E
Pediatr Res; 2013 Oct; 74(4):420-6. PubMed ID: 23823177
[TBL] [Abstract][Full Text] [Related]
13. Serum Serotonin Differentiates Between Disease Activity States in Crohn's Patients.
Manzella CR; Jayawardena D; Pagani W; Li Y; Alrefai WA; Bauer J; Jung B; Weber CR; Gill RK
Inflamm Bowel Dis; 2020 Sep; 26(10):1607-1618. PubMed ID: 32844174
[TBL] [Abstract][Full Text] [Related]
14. Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease.
Oikonomou KA; Kapsoritakis AN; Kapsoritaki AI; Manolakis AC; Tiaka EK; Tsiopoulos FD; Tsiompanidis IA; Potamianos SP
Inflamm Bowel Dis; 2011 Apr; 17(4):963-70. PubMed ID: 20629092
[TBL] [Abstract][Full Text] [Related]
15. Chemokine and cytokine levels in inflammatory bowel disease patients.
Singh UP; Singh NP; Murphy EA; Price RL; Fayad R; Nagarkatti M; Nagarkatti PS
Cytokine; 2016 Jan; 77():44-9. PubMed ID: 26520877
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic role and clinical association of serum proteinase 3 anti-neutrophil cytoplasmic antibodies in Chinese patients with inflammatory bowel disease.
Xu Y; Xu F; Li W; Li M; Dong S; Zhang Y; Norman GL; Zhao Q; Liu L
Scand J Gastroenterol; 2020 Jul; 55(7):806-813. PubMed ID: 32568566
[No Abstract] [Full Text] [Related]
17. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
18. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
19. PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease.
Horn MP; Peter AM; Righini Grunder F; Leichtle AB; Spalinger J; Schibli S; Sokollik C
PLoS One; 2018; 13(12):e0208974. PubMed ID: 30557305
[TBL] [Abstract][Full Text] [Related]
20. Serum galectins as potential biomarkers of inflammatory bowel diseases.
Yu TB; Dodd S; Yu LG; Subramanian S
PLoS One; 2020; 15(1):e0227306. PubMed ID: 31929564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]